HOME > ARCHIVE
ARCHIVE
- Korosho Proposes Revisions of NHI Pricing Rules
November 5, 2007
- J-TEC Aims at \1 Bil. with Japan's First Cultured Autologous Epidermis
November 5, 2007
- Conclusion Not yet Drawn on Causal Relation between Tamiflu and Abnormal Behavior
November 5, 2007
- Korosho Proposes More Fees for Treatment of Mental Illness
November 5, 2007
- Korosho to Order Revision of Package Insert for All Antidepressants
November 5, 2007
- REGULATORY NEWS IN BRIEF
October 29, 2007
- Working-Level Meeting Held on 5-Year Strategy
October 29, 2007
- Concerta Recommended for Approval, Depression to Be Deleted from Ritalin's Indications
October 29, 2007
- GSK Criticizes Media for Reports Linking Paxil with Suicides
October 29, 2007
- 30 New Products Approved, Including World's First Recombinant Human Serum Albumin
October 29, 2007
- First GL on Uterine Cervical Cancer Published
October 29, 2007
- NEW PRODUCTS/Genzyme's Elaprase Launched 261 Days after Application
October 29, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 29, 2007
- BUSINESS NEWS IN BRIEF
October 29, 2007
- OPINION/Why Problems Are Always Opportunities
October 29, 2007
- Pfizer Holds Career Planning Course for Female MRs
October 29, 2007
- Development of More Switch OTC Drugs Essential
October 29, 2007
- AstraZeneca Works to Create Easier-to-Work Environment for Female MRs
October 29, 2007
- Paltac to Stimulate OTC Drug Market by Merging with Kobashou
October 29, 2007
- MR Education Center Considers Radical Reform of MR Education System
October 29, 2007
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
